Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-002933

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jr. John L. Armstrong
Officer — Exec VP of Tech Operations
Period of report
Dec 31, 2017
Accepted (ET)
Mar 22, 2018 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 31, 2017M18,028$0.00A38,861D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1$0.00Dec 31, 2017M18,028D—Feb 28, 2027Common Stock18,02818,029D
Stock Option (Right to Buy Common Stock)F2$0.57holding————Feb 16, 2028Common Stock45,00045,000D
Stock Option (Right to Buy Common Stock)F3$2.18holding————Mar 1, 2025Common Stock100,000100,000D
Stock Option (Right to Buy Common Stock)F4$1.52holding————Nov 14, 2024Common Stock10,00010,000D
Stock Option (Right to Buy Common Stock)F5$3.25holding————Jul 28, 2025Common Stock15,00015,000D
Stock Option (Right to Buy Common Stock)F6$2.51holding————Mar 8, 2026Common Stock200,000200,000D

Explanation of responses